John Friend

Chief Executive Officer at KAZIA THERAPEUTICS LIMITED

54 year

Health Technology

Consumer Services

Profile

John E.
Friend is currently the Chief Executive Officer at Kazia Therapeutics Ltd.
Prior to his current position, he served as the Senior Vice President-Medical & Scientific Affairs at Helsinn Therapeutics (U.S.), Inc. from 2010 to 2017.
He then worked as the Chief Medical Officer & Vice President at Cellectar Biosciences, Inc. from 2017 to 2018, and again from 2020 to 2021.
Additionally, he held the position of Chief Medical Officer at Druggability Technologies Holdings Ltd.
(New Jersey).
Dr. Friend obtained his undergraduate degree from Southern Methodist University and his doctorate from Robert Wood Johnson Medical School.

John Friend active positions

Companies	Position	Start
KAZIA THERAPEUTICS LIMITED	Chief Executive Officer	30/04/2023

All active positions of John Friend

Former positions of John Friend

Companies	Position	End
CELLECTAR BIOSCIENCES, INC.	Chief Tech/Sci/R&D Officer	01/11/2021
CELLECTAR BIOSCIENCES, INC.	Chief Tech/Sci/R&D Officer	26/11/2018
Helsinn Therapeutics (U.S.), Inc. Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ.	Chief Tech/Sci/R&D Officer	31/03/2017
Druggability Technologies Holdings Ltd. (New Jersey)	Chief Tech/Sci/R&D Officer	-

See the detail of John Friend's experience

Training of John Friend

Southern Methodist University	Undergraduate Degree
Robert Wood Johnson Medical School	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Friend's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
KAZIA THERAPEUTICS LIMITED	Health Technology
CELLECTAR BIOSCIENCES, INC.	Health Technology

Private companies	2
Helsinn Therapeutics (U.S.), Inc. Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ.	Health Technology
Druggability Technologies Holdings Ltd. (New Jersey)

See company connections